125 related articles for article (PubMed ID: 30319277)
1. NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells.
Wu N; Zhao J; Yuan Y; Lu C; Zhu W; Jiang Q
Onco Targets Ther; 2018; 11():6369-6376. PubMed ID: 30319277
[TBL] [Abstract][Full Text] [Related]
2. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
3. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
4. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
5. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Dong L; Li Z; Xue L; Li G; Zhang C; Cai Z; Li H; Guo R
Mol Cell Biochem; 2018 Jan; 438(1-2):183-190. PubMed ID: 28795316
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
7. TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.
Yuedi D; Yuankun C; Jiaying Z; Han L; Yueqi W; Houbao L; Dexiang Z
Oncotarget; 2017 Sep; 8(41):70538-70549. PubMed ID: 29050300
[TBL] [Abstract][Full Text] [Related]
8. WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
Luo X; Liu Y; Ma S; Liu L; Xie R; Wang S
Dig Dis Sci; 2019 Sep; 64(9):2591-2599. PubMed ID: 30877610
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
10. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
11. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
[TBL] [Abstract][Full Text] [Related]
12. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.
Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z
Chem Biol Interact; 2018 Oct; 294():40-47. PubMed ID: 30125550
[TBL] [Abstract][Full Text] [Related]
13. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.
Kim M; Lee HC; Tsedensodnom O; Hartley R; Lim YS; Yu E; Merle P; Wands JR
J Hepatol; 2008 May; 48(5):780-91. PubMed ID: 18313787
[TBL] [Abstract][Full Text] [Related]
15. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.
Ren X; Rong Z; Liu X; Gao J; Xu X; Zi Y; Mu Y; Guan Y; Cao Z; Zhang Y; Zeng Z; Fan Q; Wang X; Pei Q; Wang X; Xin H; Li Z; Nie Y; Qiu Z; Li N; Sun L; Deng Y
Cancer Res; 2022 Jan; 82(1):60-74. PubMed ID: 34764205
[TBL] [Abstract][Full Text] [Related]
16. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells.
Luo X; Liu Y; Ma S; Liu L; Xie R; Li M; Shen P; Wang S
Gene; 2018 Jul; 662():110-117. PubMed ID: 29596884
[TBL] [Abstract][Full Text] [Related]
17. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
18. Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma.
Ji J; Yamashita T; Wang XW
Cell Biosci; 2011 Jan; 1(1):4. PubMed ID: 21711587
[TBL] [Abstract][Full Text] [Related]
19. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract][Full Text] [Related]
20. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
